Hi, we are looking for gut microbiome by targeting V3V4 and ITS2 regions through Illumina-MiSeq platform and would like to analyse the data using QIIME and other bioinformatics pipelines. Our data consists of 500,000 to 800,000 reads per sample. The comparative analysis would range from 40 to 100 samples (maximum). In this regard, it would be grateful, if someone tell us the suitable configuration (RAM, hard disk space, processor, number of cores, number of threads etc) for buying the workstation.
-
-
Are you working within a certain budget or is that not a consideration?
You will find several workstation threads here (and elsewhere on the net) and most of those recommendations should work well for you. In general try to maximize the RAM, get a solid state drive for OS, go with the second or third fastest processor(s) you can afford (not much gain in getting the top of the line/most expensive CPU) and finally as much spinning disk as you can fit in your remaining budget. -
Minimum configuration required for analyzing MiSeq data (by V3V4, ITS2) on QIIME
Hi GenoMax, thankyou for your reply. I would like to know the minimum configuration required for analyzing the data which I have posted earlier, so that I can plan for a workstation within our budget accordingly. [Whether 32 GB RAM, Intel® Core™ i7-6700 CPU @ 3.40GHz × 8 processor (http://ark.intel.com/products/88196/...up-to-4_00-GHz) , 1 TB hard disk space are sufficient and optimal for such analysis?, if higher configuration is required, what will you suggest?].Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment